| $376M | ||
| $350M | ||
| $215M | ||
| $107M | ||
| $100M | ||
| $99M |
Buys | $656,964 | 5 | 100 |
Sells | $0 | 0 | 0 |
| Hargroves Thomas Jeffrey | director | 1 | $490,271 | 0 | $0 | $490,271 |
| Werth Peter J. | director | 1 | $98,053 | 0 | $0 | $98,053 |
| Schaffer Shane J. | Chief Executive Officer | 1 | $34,317 | 0 | $0 | $34,317 |
| Callahan Jennifer L. | SVP and CFO | 1 | $24,515 | 0 | $0 | $24,515 |
| Brams Matthew | EVP and Chief Medical Officer | 1 | $9,808 | 0 | $0 | $9,808 |
Cingulate Inc. is a biopharmaceutical enterprise currently in its clinical development phase, dedicated to devising therapeutic options for attention-deficit/hyperactivity disorder (ADHD). Leading its pipeline for ADHD are two drug candidates: CTx-1301 (dexmethylphenidate), which is currently progressing through Phase 3 clinical trials, and CTx-1302 (dextroamphetamine). The company is also engaged in the advancement of CTx-2103, a candidate intended for the management of anxiety disorders. Founded in 2012, Cingulate Inc. maintains its corporate headquarters in Kansas City, Kansas.
Over the last 12 months, insiders at Cingulate Inc. have bought $656,964 and sold $0 worth of Cingulate Inc. stock.
On average, over the past 5 years, insiders at Cingulate Inc. have bought $508,056 and sold $11,525 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hargroves Thomas Jeffrey (director) — $490,271. Werth Peter J. (director) — $98,053. Schaffer Shane J. (Chief Executive Officer) — $34,317.
The last purchase of 97,276 shares for transaction amount of $490,271 was made by Hargroves Thomas Jeffrey (director) on 2026‑02‑13.
| 2026-02-13 | Hargroves Thomas Jeffrey | director | 97,276 1.4576% | $5.04 | $490,271 | -6.33% | ||
| 2026-02-06 | Werth Peter J. | director | 19,455 0.2272% | $5.04 | $98,053 | -24.29% | ||
| 2026-02-06 | Schaffer Shane J. | Chief Executive Officer | 6,809 0.0795% | $5.04 | $34,317 | -24.29% | ||
| 2026-02-06 | Callahan Jennifer L. | SVP and CFO | 4,864 0.0568% | $5.04 | $24,515 | -24.29% | ||
| 2026-02-06 | Brams Matthew | EVP and Chief Medical Officer | 1,946 0.0227% | $5.04 | $9,808 | -24.29% | ||
| 2024-08-15 | Sale | Myers Laurie | EVP and COO | 202 0.0346% | $4.17 | $841 | -9.48% | |
| 2023-09-15 | Callahan Jennifer L. | Corporate Controller | 5,000 0.031% | $0.67 | $3,349 | -91.95% | ||
| 2023-08-11 | Werth Peter J. | director | 1.82M 16.1208% | $0.55 | $1M | -88.68% | ||
| 2023-05-15 | Callahan Jennifer L. | Corporate Controller | 2,000 0.0184% | $1.01 | $2,020 | -61.39% | ||
| 2023-05-12 | Callahan Jennifer L. | Corporate Controller | 4,000 0.0374% | $1.08 | $4,320 | -62.62% | ||
| 2022-12-16 | Schaffer Shane J. | Chief Executive Officer | 10,000 0.0879% | $1.02 | $10,166 | -11.54% | ||
| 2022-12-14 | Callahan Jennifer L. | Corporate Controller | 7,548 0.0728% | $0.99 | $7,468 | +0.16% | ||
| 2022-12-14 | Schaffer Shane J. | Chief Executive Officer | 13,267 0.1305% | $1.01 | $13,400 | +0.16% | ||
| 2022-12-13 | Werth Peter J. | director | 28,934 0.2505% | $0.98 | $28,422 | -9.36% | ||
| 2022-12-13 | Schaffer Shane J. | Chief Executive Officer | 1,733 0.0154% | $1.01 | $1,750 | -9.36% | ||
| 2022-11-29 | Callahan Jennifer L. | Corporate Controller | 1,530 0.0144% | $0.98 | $1,499 | +0.64% | ||
| 2022-11-28 | Callahan Jennifer L. | Corporate Controller | 3,487 0.0304% | $0.98 | $3,417 | -7.00% | ||
| 2022-11-23 | Myers Laurie | EVP and COO | 1,111 0.0098% | $0.90 | $1,000 | +2.74% | ||
| 2022-11-23 | Gilgallon Craig S. | EVP, GC and Secretary | 3,575 0.0295% | $0.84 | $3,003 | +2.74% | ||
| 2022-11-22 | GIVENS GREGG WM | director | 85,000 0.766% | $0.88 | $74,851 | +6.90% |
| Increased Positions | 13 | +118.18% | 257,578 | +88.72% |
| Decreased Positions | 5 | -45.45% | 34,537 | -11.9% |
| New Positions | 7 | New | 106,510 | New |
| Sold Out Positions | <1 | Sold Out | 10,772 | Sold Out |
| Total Postitions | 19 | +72.73% | 513,369 | +76.82% |
| Kestra Advisory Services, Llc | $412.00 | 1.34% | 94,021 | +94,021 | New | 2025-09-30 |
| Vanguard Group Inc | $323.00 | 1.05% | 73,797 | +38,420 | +108.6% | 2025-09-30 |
| Geode Capital Management, Llc | $186.00 | 0.61% | 42,406 | +10,250 | +31.88% | 2025-09-30 |
| Quantum Private Wealth, Llc | $105.00 | 0.34% | 24,000 | +14,000 | +140% | 2025-09-30 |
| Lpl Financial Llc | $89.00 | 0.29% | 20,250 | +8,075 | +66.32% | 2025-09-30 |
| Northern Trust Corp | $59.00 | 0.19% | 13,384 | +13,384 | New | 2025-09-30 |
| Virtu Financial Llc | $47.00 | 0.15% | 10,772 | -2,579 | -19.32% | 2025-09-30 |
| Bank Of America Corp /De/ | $33.00 | 0.11% | 7,455 | -46 | -0.61% | 2025-09-30 |
| Harbour Investments, Inc. | $10.00 | 0.03% | 2,275 | +2,275 | New | 2025-09-30 |
| Ubs Group Ag | $6.00 | 0.02% | 1,298 | -11,347 | -89.73% | 2025-09-30 |